Free Trial

Spectral Medical (TSE:EDT) Stock Price Crosses Below 50-Day Moving Average - Should You Sell?

Spectral Medical logo with Medical background

Spectral Medical Inc. (TSE:EDT - Get Free Report)'s share price passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of C$0.63 and traded as low as C$0.56. Spectral Medical shares last traded at C$0.58, with a volume of 45,960 shares changing hands.

Spectral Medical Stock Up 3.4 %

The firm has a market capitalization of C$168.75 million, a P/E ratio of -8.57 and a beta of 0.96. The company has a debt-to-equity ratio of 26.03, a quick ratio of 0.45 and a current ratio of 0.61. The stock has a 50 day moving average of C$0.62 and a 200-day moving average of C$0.55.

Spectral Medical (TSE:EDT - Get Free Report) last posted its quarterly earnings results on Friday, August 9th. The company reported C($0.02) earnings per share (EPS) for the quarter. The firm had revenue of C$0.47 million for the quarter. Research analysts predict that Spectral Medical Inc. will post -0.05 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Paul M. Walker sold 150,000 shares of Spectral Medical stock in a transaction on Friday, September 13th. The stock was sold at an average price of C$0.65, for a total value of C$97,500.00. Company insiders own 18.18% of the company's stock.

About Spectral Medical

(Get Free Report)

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.

Further Reading

→ Central Bank Abandons USD (From Desko Digital) (Ad)

Should you invest $1,000 in Spectral Medical right now?

Before you consider Spectral Medical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.

While Spectral Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines